Mesalazine and Lactobacillus casei, alone or in combination, prevent recurrence of symptomatic uncomplicated diverticular colon disease

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1539, 2006-01, pp. : 15-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mesalazine for diverticular disease of the colon – a new role for an old drug

By Tursi Antonio  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 1, 2005-01 ,pp. : 69-74

Informa Healthcare

Access to resources Recommend Favorite

Epidemiology and Management of Diverticular Disease of the Colon

By Kang J-Y.  

Drugs & Aging, Vol. 21, Iss. 4, 2004-01 ,pp. : 211-228

Adis International

Access to resources Recommend Favorite

Central and Mucosal Immunities are Modified by Non Adsorbable Antibiotic Treatment in Uncomplicated Diverticular Disease

By  

Mini Reviews in Medicinal Chemistry, Vol. 16, Iss. 3, 2016-02 ,pp. : 218-221

Bentham Science Publishers

Access to resources Recommend Favorite

Can EGFR-Tyrosine Kinase Inhibitors (TKI) Alone Without Talc Pleurodesis Prevent Recurrence of Malignant Pleural Effusion (MPE) in Lung Adenocarcinoma

By  

Current Drug Discovery Technologies, Vol. 13, Iss. 2, 2016-08 ,pp. : 68-76

Bentham Science Publishers

Access to resources Recommend Favorite

Mesalazine for the treatment of inflammatory bowel disease

By Criscuoli Valeria  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 12, 2013-08 ,pp. : 1669-1678

Informa Healthcare

Access to resources Recommend Favorite